Investors & Media Home

Download Mesoblast Corporate Backgrounder

Mesoblast Corporate Backgrounder (350 KB)

Mesoblast is a world leader in developing innovative cellular medicines.

The Company has established what it believes is the industry's most clinically advanced and diverse portfolio of cell-based product candidates ... More

Latest ASX AnnouncementsMore
13 December 2018
Meetings Held With FDA Support MSB's Planned GVHD Filing
... 
05 December 2018
Response to ASX query
... 
30 November 2018
Results of Meeting
... 
30 November 2018
Presentation to 2018 Annual General Meeting
... 
Upcoming EventsMore
There are currently no events scheduled.
Stock QuoteMore
Exchange :ASX
Price :A$1.14
Change : Stock is Down 0.06 (5.00%)
Volume :1,831,047
Data as of 14 December 2018 4:11 p.m. ET
Data provided by Nasdaq Minimum 15 minutes delay
Download Documentation First Quarter Results Presentation
Download Documentation 2018 Annual Report
Download Documentation Financial Results for the 2018 Full Financial Year, 4th Quarter Ended June 30, 2018
Download Documentation Financial Results for the Period Ended September 30, 2017
E-mail Alerts
Sign up to receive e-mail alerts.

Share Price ASX: MSB  AUD 1.14 as of Dec 14, 2018